

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.32519023 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.32519023 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.32519023 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.32519023 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.32519023 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.32519023 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41805459 |
| 8 | response to peptidoglycan (GO:0032494) | 5.25726905 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.09661485 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.81064220 |
| 11 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.76242195 |
| 12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.55192482 |
| 13 | response to host immune response (GO:0052572) | 4.55192482 |
| 14 | desmosome organization (GO:0002934) | 4.52182584 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 4.48522367 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.22217109 |
| 17 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.18796701 |
| 18 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.14201148 |
| 19 | response to host (GO:0075136) | 4.08368131 |
| 20 | response to host defenses (GO:0052200) | 4.08368131 |
| 21 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.08368131 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.03692956 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.94185655 |
| 24 | respiratory burst (GO:0045730) | 3.89342262 |
| 25 | reactive oxygen species biosynthetic process (GO:1903409) | 3.88532480 |
| 26 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.85385818 |
| 27 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.84987551 |
| 28 | cell communication involved in cardiac conduction (GO:0086065) | 3.79993290 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.76047729 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.75122796 |
| 31 | granulocyte activation (GO:0036230) | 3.73716088 |
| 32 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.62973070 |
| 33 | natural killer cell mediated immunity (GO:0002228) | 3.62973070 |
| 34 | neutrophil activation (GO:0042119) | 3.62322272 |
| 35 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.61946391 |
| 36 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.59919174 |
| 37 | superoxide anion generation (GO:0042554) | 3.59202228 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.59164868 |
| 39 | microglial cell activation (GO:0001774) | 3.52892783 |
| 40 | cellular response to interferon-alpha (GO:0035457) | 3.50049802 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.47995079 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.37677786 |
| 43 | neutrophil mediated immunity (GO:0002446) | 3.35368595 |
| 44 | receptor recycling (GO:0001881) | 3.34260814 |
| 45 | intestinal epithelial cell development (GO:0060576) | 3.32382616 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.31321795 |
| 47 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.31033313 |
| 48 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.29466338 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.29466338 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.29412866 |
| 51 | I-kappaB phosphorylation (GO:0007252) | 3.29053999 |
| 52 | positive regulation of interferon-beta production (GO:0032728) | 3.27518616 |
| 53 | positive regulation of heat generation (GO:0031652) | 3.26848025 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25433289 |
| 55 | response to interferon-alpha (GO:0035455) | 3.23367886 |
| 56 | type I interferon signaling pathway (GO:0060337) | 3.22630966 |
| 57 | cellular response to type I interferon (GO:0071357) | 3.22630966 |
| 58 | regulation of mononuclear cell migration (GO:0071675) | 3.22256341 |
| 59 | response to type I interferon (GO:0034340) | 3.19636877 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17839682 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.16348128 |
| 62 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.16193640 |
| 63 | apical protein localization (GO:0045176) | 3.15391135 |
| 64 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.15222705 |
| 65 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.14707417 |
| 66 | macrophage activation (GO:0042116) | 3.14396280 |
| 67 | regulation of fever generation (GO:0031620) | 3.13544856 |
| 68 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.13359348 |
| 69 | angiotensin maturation (GO:0002003) | 3.12678988 |
| 70 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.12170670 |
| 71 | neuron recognition (GO:0008038) | 3.11275847 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 3.11115176 |
| 73 | cell adhesion mediated by integrin (GO:0033627) | 3.10564931 |
| 74 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.10218137 |
| 75 | leukocyte mediated cytotoxicity (GO:0001909) | 3.09984425 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.07573965 |
| 77 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.07062409 |
| 78 | hemidesmosome assembly (GO:0031581) | 3.05408034 |
| 79 | axonal fasciculation (GO:0007413) | 3.05169309 |
| 80 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.02105643 |
| 81 | positive regulation of type 2 immune response (GO:0002830) | 2.98818008 |
| 82 | negative regulation of viral genome replication (GO:0045071) | 2.97547638 |
| 83 | regulation of chemokine biosynthetic process (GO:0045073) | 2.96415524 |
| 84 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94806268 |
| 85 | regulation of bile acid biosynthetic process (GO:0070857) | 2.93020731 |
| 86 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.92742654 |
| 87 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.92230616 |
| 88 | B cell mediated immunity (GO:0019724) | 2.89651872 |
| 89 | cell communication by electrical coupling (GO:0010644) | 2.86787763 |
| 90 | positive regulation of leukocyte degranulation (GO:0043302) | 2.84708589 |
| 91 | positive regulation of interleukin-12 production (GO:0032735) | 2.84000213 |
| 92 | T-helper 1 type immune response (GO:0042088) | 2.82857749 |
| 93 | regulation of integrin activation (GO:0033623) | 2.81523070 |
| 94 | myeloid leukocyte mediated immunity (GO:0002444) | 2.81013073 |
| 95 | negative regulation of interleukin-12 production (GO:0032695) | 2.81001446 |
| 96 | cellular extravasation (GO:0045123) | 2.80370750 |
| 97 | leukocyte aggregation (GO:0070486) | 2.77944434 |
| 98 | positive regulation of antigen processing and presentation (GO:0002579) | 2.77302653 |
| 99 | regulation of mast cell degranulation (GO:0043304) | 2.76959866 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.76842044 |
| 101 | nerve growth factor signaling pathway (GO:0038180) | 2.75953078 |
| 102 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.74746792 |
| 103 | lymphocyte chemotaxis (GO:0048247) | 2.73785784 |
| 104 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72533740 |
| 105 | myeloid dendritic cell differentiation (GO:0043011) | 2.72457459 |
| 106 | mating behavior (GO:0007617) | 2.71382084 |
| 107 | detection of external biotic stimulus (GO:0098581) | 2.71170176 |
| 108 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.69945181 |
| 109 | detection of other organism (GO:0098543) | 2.69907682 |
| 110 | negative regulation of interleukin-17 production (GO:0032700) | 2.69611290 |
| 111 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.69363983 |
| 112 | endoplasmic reticulum organization (GO:0007029) | 2.69236339 |
| 113 | regulation of leukocyte degranulation (GO:0043300) | 2.67930851 |
| 114 | cardiac conduction (GO:0061337) | 2.67611773 |
| 115 | positive regulation of interleukin-6 production (GO:0032755) | 2.67297410 |
| 116 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.65684909 |
| 117 | cytokine secretion (GO:0050663) | 2.65048357 |
| 118 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63638067 |
| 119 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62665956 |
| 120 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.62306130 |
| 121 | regulation of hypersensitivity (GO:0002883) | 2.61481236 |
| 122 | intestinal absorption (GO:0050892) | 2.60837488 |
| 123 | apoptotic cell clearance (GO:0043277) | 2.59582439 |
| 124 | sodium ion export (GO:0071436) | 2.58252825 |
| 125 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.58144069 |
| 126 | neutrophil chemotaxis (GO:0030593) | 2.57693168 |
| 127 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.57459303 |
| 128 | regulation of RIG-I signaling pathway (GO:0039535) | 2.57374395 |
| 129 | phagosome maturation (GO:0090382) | 2.57189521 |
| 130 | carnitine shuttle (GO:0006853) | 2.56654596 |
| 131 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.56481055 |
| 132 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.56411111 |
| 133 | detection of biotic stimulus (GO:0009595) | 2.55106032 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.54541885 |
| 135 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.52972138 |
| 136 | regulation of cholesterol homeostasis (GO:2000188) | 2.52616889 |
| 137 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.52568017 |
| 138 | regulation of pigment cell differentiation (GO:0050932) | 2.52488136 |
| 139 | carnitine transport (GO:0015879) | 2.50996960 |
| 140 | amino-acid betaine transport (GO:0015838) | 2.50996960 |
| 141 | auditory receptor cell differentiation (GO:0042491) | 2.50240496 |
| 142 | regulation of ARF protein signal transduction (GO:0032012) | 2.49710914 |
| 143 | negative regulation of dendrite development (GO:2000171) | 2.48408123 |
| 144 | peptidyl-threonine modification (GO:0018210) | 2.46809560 |
| 145 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.46258072 |
| 146 | dopamine receptor signaling pathway (GO:0007212) | 2.44165644 |
| 147 | COPII vesicle coating (GO:0048208) | 2.41817025 |
| 148 | regulation of RNA export from nucleus (GO:0046831) | 2.41140095 |
| 149 | cell migration in hindbrain (GO:0021535) | 2.38755844 |
| 150 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.38033874 |
| 151 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.37902465 |
| 152 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.37373508 |
| 153 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.37244088 |
| 154 | dendritic spine morphogenesis (GO:0060997) | 2.36548321 |
| 155 | cellular sodium ion homeostasis (GO:0006883) | 2.35958285 |
| 156 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.35562293 |
| 157 | intracellular lipid transport (GO:0032365) | 2.34736040 |
| 158 | asymmetric protein localization (GO:0008105) | 2.34505763 |
| 159 | establishment of nucleus localization (GO:0040023) | 2.34018189 |
| 160 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.33620453 |
| 161 | detection of calcium ion (GO:0005513) | 2.33572065 |
| 162 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.33451502 |
| 163 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.33071155 |
| 164 | histone H3-K36 demethylation (GO:0070544) | 2.30993787 |
| 165 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.30029322 |
| 166 | carnitine transmembrane transport (GO:1902603) | 2.29896857 |
| 167 | glutamate secretion (GO:0014047) | 2.29373762 |
| 168 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.29353402 |
| 169 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.28715289 |
| 170 | presynaptic membrane assembly (GO:0097105) | 2.28320835 |
| 171 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.27426813 |
| 172 | dendrite morphogenesis (GO:0048813) | 2.26415264 |
| 173 | positive regulation of glucose import (GO:0046326) | 2.25996503 |
| 174 | lipoprotein transport (GO:0042953) | 2.25411851 |
| 175 | vocalization behavior (GO:0071625) | 2.24633045 |
| 176 | positive regulation of glucose transport (GO:0010828) | 2.22466367 |
| 177 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.22347117 |
| 178 | glucocorticoid biosynthetic process (GO:0006704) | 2.21712291 |
| 179 | peptidyl-threonine phosphorylation (GO:0018107) | 2.21655494 |
| 180 | neuron remodeling (GO:0016322) | 2.21548288 |
| 181 | epithelial cell-cell adhesion (GO:0090136) | 2.21542762 |
| 182 | cardiac muscle cell action potential (GO:0086001) | 2.21105006 |
| 183 | response to nerve growth factor (GO:1990089) | 2.20904298 |
| 184 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.20904298 |
| 185 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.19955503 |
| 186 | regulation of keratinocyte proliferation (GO:0010837) | 2.17506223 |
| 187 | gastrulation with mouth forming second (GO:0001702) | 2.17407583 |
| 188 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.16421641 |
| 189 | N-glycan processing (GO:0006491) | 2.15645921 |
| 190 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.14425883 |
| 191 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.13984768 |
| 192 | labyrinthine layer development (GO:0060711) | 2.13013978 |
| 193 | regulation of Rac protein signal transduction (GO:0035020) | 2.12832816 |
| 194 | glucocorticoid metabolic process (GO:0008211) | 2.12361736 |
| 195 | innervation (GO:0060384) | 2.12105750 |
| 196 | mitotic sister chromatid cohesion (GO:0007064) | 2.11259397 |
| 197 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.10847405 |
| 198 | nuclear pore complex assembly (GO:0051292) | 2.10140449 |
| 199 | Golgi to endosome transport (GO:0006895) | 2.09390022 |
| 200 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.09304184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.83929041 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.76344739 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.43809272 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99991949 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.69227674 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.63302414 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39264405 |
| 8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.30741311 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.12318163 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02445611 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.91762196 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.73772558 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.72407121 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.68483348 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65791352 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.56829664 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.56105023 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54752462 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.43688895 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41213315 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20003466 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.14798536 |
| 23 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.13233358 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.98966475 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98954203 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87619618 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.80625085 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76881936 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.74707068 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60817613 |
| 31 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.60270973 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59360935 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55076856 |
| 34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55076856 |
| 35 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.54243390 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52267154 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52157401 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.52137330 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52086870 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50767420 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49851235 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48186521 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43331758 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43293625 |
| 45 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.42576373 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41239326 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40670190 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40010696 |
| 49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38202664 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36034993 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.35945813 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35724784 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34478019 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33993582 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33963601 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30938953 |
| 57 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.30444975 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30262020 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29939211 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29003993 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28592925 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27471918 |
| 63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27125171 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26077698 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26036337 |
| 66 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25887541 |
| 67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.25832361 |
| 68 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25436486 |
| 69 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25034565 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24732336 |
| 71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23165373 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22515733 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22206992 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20491963 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20316396 |
| 76 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19939560 |
| 77 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19473871 |
| 78 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.19428112 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.19428112 |
| 80 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19357735 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18874292 |
| 82 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.18092795 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14973765 |
| 84 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14540155 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14243322 |
| 86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14140046 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14035249 |
| 88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13960704 |
| 89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13874499 |
| 90 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.12775173 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11803406 |
| 92 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11549336 |
| 93 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11325982 |
| 94 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11064369 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10799574 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10767717 |
| 97 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.10088043 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10085620 |
| 99 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09889225 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08874717 |
| 101 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.08343237 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08251893 |
| 103 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08202617 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07893646 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.07326517 |
| 106 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07279251 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06099224 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05826937 |
| 109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05799132 |
| 110 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05612336 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05583547 |
| 112 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05541935 |
| 113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04983343 |
| 114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.04822902 |
| 115 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04465172 |
| 116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04109124 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04109124 |
| 118 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03234367 |
| 119 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02959185 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02811129 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02764852 |
| 122 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02691914 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02397485 |
| 124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01898818 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01834432 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00774341 |
| 127 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00479964 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00380089 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00048357 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99797528 |
| 131 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98557026 |
| 132 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97209464 |
| 133 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96638097 |
| 134 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96600931 |
| 135 | MYB_26560356_Chip-Seq_TH2_Human | 0.95504696 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90817547 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90271192 |
| 138 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89943433 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88956642 |
| 140 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87953334 |
| 141 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87143985 |
| 142 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86926161 |
| 143 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85380563 |
| 144 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83269985 |
| 145 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82687393 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79596812 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79271085 |
| 148 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.79140286 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78313474 |
| 150 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78126372 |
| 151 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77455618 |
| 152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76407789 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75909797 |
| 154 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.75906867 |
| 155 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75454232 |
| 156 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.72419912 |
| 157 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.72335152 |
| 158 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.71806845 |
| 159 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.71370090 |
| 160 | MYB_26560356_Chip-Seq_TH1_Human | 0.71022337 |
| 161 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70907923 |
| 162 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.70831136 |
| 163 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.70396896 |
| 164 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.70267319 |
| 165 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.68677686 |
| 166 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66979153 |
| 167 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.66591890 |
| 168 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66519603 |
| 169 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.66313961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.31998795 |
| 2 | MP0003436_decreased_susceptibility_to | 3.97628968 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.90089793 |
| 4 | MP0005409_darkened_coat_color | 3.85451874 |
| 5 | MP0003303_peritoneal_inflammation | 3.65402818 |
| 6 | MP0009785_altered_susceptibility_to | 3.47772910 |
| 7 | MP0004270_analgesia | 3.37243240 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.24625831 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 3.24592539 |
| 10 | MP0002419_abnormal_innate_immunity | 3.10062872 |
| 11 | MP0002009_preneoplasia | 2.87695377 |
| 12 | MP0002822_catalepsy | 2.76371239 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.75314231 |
| 14 | MP0006082_CNS_inflammation | 2.69685223 |
| 15 | MP0005025_abnormal_response_to | 2.58055269 |
| 16 | MP0001188_hyperpigmentation | 2.53359594 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.53212622 |
| 18 | MP0004510_myositis | 2.50690147 |
| 19 | MP0003123_paternal_imprinting | 2.49138660 |
| 20 | MP0005387_immune_system_phenotype | 2.41710186 |
| 21 | MP0001790_abnormal_immune_system | 2.41710186 |
| 22 | MP0003724_increased_susceptibility_to | 2.41212908 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.25965295 |
| 24 | MP0002006_tumorigenesis | 2.24325717 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.22586783 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.20554768 |
| 27 | MP0000685_abnormal_immune_system | 2.19748518 |
| 28 | MP0004947_skin_inflammation | 2.18926428 |
| 29 | MP0000566_synostosis | 2.14872820 |
| 30 | MP0005076_abnormal_cell_differentiation | 2.14161252 |
| 31 | MP0002909_abnormal_adrenal_gland | 2.13124407 |
| 32 | MP0003890_abnormal_embryonic-extraembry | 2.11907107 |
| 33 | MP0000537_abnormal_urethra_morphology | 2.05357744 |
| 34 | MP0003283_abnormal_digestive_organ | 2.01682824 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.99289208 |
| 36 | MP0002723_abnormal_immune_serum | 1.98418675 |
| 37 | MP0009764_decreased_sensitivity_to | 1.97150273 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.94236347 |
| 39 | MP0000462_abnormal_digestive_system | 1.92421020 |
| 40 | MP0003941_abnormal_skin_development | 1.88493691 |
| 41 | MP0003448_altered_tumor_morphology | 1.86303131 |
| 42 | MP0009278_abnormal_bone_marrow | 1.84862610 |
| 43 | MP0001800_abnormal_humoral_immune | 1.84185303 |
| 44 | MP0000604_amyloidosis | 1.83551215 |
| 45 | MP0003315_abnormal_perineum_morphology | 1.81791342 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.80418671 |
| 47 | MP0003868_abnormal_feces_composition | 1.80066107 |
| 48 | MP0001819_abnormal_immune_cell | 1.79044891 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.77997787 |
| 50 | MP0000858_altered_metastatic_potential | 1.76323043 |
| 51 | MP0003075_altered_response_to | 1.75937492 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.72412005 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.72103502 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.70417839 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.70067858 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.69059614 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.64683678 |
| 58 | MP0005310_abnormal_salivary_gland | 1.64362197 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.60368377 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.57183670 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.56792365 |
| 62 | MP0010307_abnormal_tumor_latency | 1.55402409 |
| 63 | MP0005671_abnormal_response_to | 1.51799178 |
| 64 | MP0003122_maternal_imprinting | 1.51187119 |
| 65 | MP0004858_abnormal_nervous_system | 1.50416518 |
| 66 | MP0003091_abnormal_cell_migration | 1.48800922 |
| 67 | MP0003787_abnormal_imprinting | 1.45892290 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 1.45825350 |
| 69 | MP0002796_impaired_skin_barrier | 1.45727235 |
| 70 | MP0005360_urolithiasis | 1.42834247 |
| 71 | MP0008469_abnormal_protein_level | 1.40169166 |
| 72 | MP0003635_abnormal_synaptic_transmissio | 1.36937201 |
| 73 | MP0008438_abnormal_cutaneous_collagen | 1.36006106 |
| 74 | MP0000579_abnormal_nail_morphology | 1.35180754 |
| 75 | MP0000778_abnormal_nervous_system | 1.34739574 |
| 76 | MP0002405_respiratory_system_inflammati | 1.34556081 |
| 77 | MP0005166_decreased_susceptibility_to | 1.33577088 |
| 78 | MP0003880_abnormal_central_pattern | 1.31561136 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.30901762 |
| 80 | MP0002098_abnormal_vibrissa_morphology | 1.29508952 |
| 81 | MP0002184_abnormal_innervation | 1.28459821 |
| 82 | MP0001664_abnormal_digestion | 1.28203863 |
| 83 | MP0000343_altered_response_to | 1.27350286 |
| 84 | MP0005164_abnormal_response_to | 1.27157610 |
| 85 | MP0010386_abnormal_urinary_bladder | 1.24238711 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 1.22987806 |
| 87 | MP0009379_abnormal_foot_pigmentation | 1.21309502 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 1.18806977 |
| 89 | MP0001545_abnormal_hematopoietic_system | 1.18806977 |
| 90 | MP0004084_abnormal_cardiac_muscle | 1.18718731 |
| 91 | MP0005390_skeleton_phenotype | 1.18296168 |
| 92 | MP0008057_abnormal_DNA_replication | 1.18091881 |
| 93 | MP0002734_abnormal_mechanical_nocicepti | 1.16456633 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 1.15491239 |
| 95 | MP0000383_abnormal_hair_follicle | 1.13712100 |
| 96 | MP0001958_emphysema | 1.12691212 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 1.09550269 |
| 98 | MP0000716_abnormal_immune_system | 1.09235615 |
| 99 | MP0005257_abnormal_intraocular_pressure | 1.08499799 |
| 100 | MP0002063_abnormal_learning/memory/cond | 1.08480651 |
| 101 | MP0005187_abnormal_penis_morphology | 1.08166548 |
| 102 | MP0002254_reproductive_system_inflammat | 1.07743333 |
| 103 | MP0001853_heart_inflammation | 1.05070391 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 1.03214423 |
| 105 | MP0000371_diluted_coat_color | 1.02287869 |
| 106 | MP0005174_abnormal_tail_pigmentation | 1.01829694 |
| 107 | MP0003121_genomic_imprinting | 1.01614184 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.97098185 |
| 109 | MP0005386_behavior/neurological_phenoty | 0.95784783 |
| 110 | MP0004924_abnormal_behavior | 0.95784783 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.95008114 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.94391448 |
| 113 | MP0005085_abnormal_gallbladder_physiolo | 0.93593651 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.93354269 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 0.93256665 |
| 116 | MP0003045_fibrosis | 0.91150808 |
| 117 | MP0004811_abnormal_neuron_physiology | 0.90307379 |
| 118 | MP0002398_abnormal_bone_marrow | 0.88561285 |
| 119 | MP0000955_abnormal_spinal_cord | 0.88045505 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.87987486 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.87861435 |
| 122 | MP0004883_abnormal_blood_vessel | 0.87088808 |
| 123 | MP0004215_abnormal_myocardial_fiber | 0.86519080 |
| 124 | MP0002064_seizures | 0.86230717 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.84154361 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.83338449 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.80885156 |
| 128 | MP0009763_increased_sensitivity_to | 0.80403445 |
| 129 | MP0000762_abnormal_tongue_morphology | 0.80363351 |
| 130 | MP0000377_abnormal_hair_follicle | 0.80313227 |
| 131 | MP0001501_abnormal_sleep_pattern | 0.77897337 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.77671728 |
| 133 | MP0001177_atelectasis | 0.77446678 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.77061273 |
| 135 | MP0003632_abnormal_nervous_system | 0.76849252 |
| 136 | MP0005023_abnormal_wound_healing | 0.75430668 |
| 137 | MP0000477_abnormal_intestine_morphology | 0.75088518 |
| 138 | MP0000534_abnormal_ureter_morphology | 0.74938662 |
| 139 | MP0002429_abnormal_blood_cell | 0.74755805 |
| 140 | MP0003795_abnormal_bone_structure | 0.74578048 |
| 141 | MP0004484_altered_response_of | 0.74204450 |
| 142 | MP0003828_pulmonary_edema | 0.74042788 |
| 143 | MP0010630_abnormal_cardiac_muscle | 0.73837213 |
| 144 | MP0003634_abnormal_glial_cell | 0.73671417 |
| 145 | MP0003385_abnormal_body_wall | 0.73507792 |
| 146 | MP0004085_abnormal_heartbeat | 0.72919421 |
| 147 | MP0000767_abnormal_smooth_muscle | 0.71996707 |
| 148 | MP0000249_abnormal_blood_vessel | 0.71393239 |
| 149 | MP0003943_abnormal_hepatobiliary_system | 0.71005925 |
| 150 | MP0003935_abnormal_craniofacial_develop | 0.70910757 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.70820033 |
| 152 | MP0005365_abnormal_bile_salt | 0.70560212 |
| 153 | MP0001984_abnormal_olfaction | 0.69822334 |
| 154 | MP0009703_decreased_birth_body | 0.68785439 |
| 155 | MP0003329_amyloid_beta_deposits | 0.68606089 |
| 156 | MP0002136_abnormal_kidney_physiology | 0.68535902 |
| 157 | MP0003861_abnormal_nervous_system | 0.68470282 |
| 158 | MP0002882_abnormal_neuron_morphology | 0.67924079 |
| 159 | MP0005248_abnormal_Harderian_gland | 0.67206456 |
| 160 | MP0009672_abnormal_birth_weight | 0.67015714 |
| 161 | MP0005197_abnormal_uvea_morphology | 0.66945109 |
| 162 | MP0004859_abnormal_synaptic_plasticity | 0.66923814 |
| 163 | MP0008004_abnormal_stomach_pH | 0.66555356 |
| 164 | MP0001765_abnormal_ion_homeostasis | 0.66265573 |
| 165 | MP0000470_abnormal_stomach_morphology | 0.65701151 |
| 166 | MP0002572_abnormal_emotion/affect_behav | 0.65658459 |
| 167 | MP0006054_spinal_hemorrhage | 0.65636711 |
| 168 | MP0002876_abnormal_thyroid_physiology | 0.65374732 |
| 169 | MP0009840_abnormal_foam_cell | 0.63798317 |
| 170 | MP0003195_calcinosis | 0.63368784 |
| 171 | MP0002081_perinatal_lethality | 0.63137607 |
| 172 | MP0002557_abnormal_social/conspecific_i | 0.62960822 |
| 173 | MP0002735_abnormal_chemical_nociception | 0.61986855 |
| 174 | MP0008569_lethality_at_weaning | 0.61706621 |
| 175 | MP0002168_other_aberrant_phenotype | 0.61454378 |
| 176 | MP0000427_abnormal_hair_cycle | 0.61241813 |
| 177 | MP0000516_abnormal_urinary_system | 0.59430856 |
| 178 | MP0005367_renal/urinary_system_phenotyp | 0.59430856 |
| 179 | MP0000689_abnormal_spleen_morphology | 0.56985925 |
| 180 | MP0000627_abnormal_mammary_gland | 0.56135557 |
| 181 | MP0002722_abnormal_immune_system | 0.55788659 |
| 182 | MP0010234_abnormal_vibrissa_follicle | 0.55564513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.90254795 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.57444363 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.47129126 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.75155928 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 5.12509582 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.89297053 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.72055156 |
| 8 | Prostate neoplasm (HP:0100787) | 4.47348860 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.37266367 |
| 10 | Gingivitis (HP:0000230) | 4.23447089 |
| 11 | Papillary thyroid carcinoma (HP:0002895) | 3.76199535 |
| 12 | Orchitis (HP:0100796) | 3.64516336 |
| 13 | Periodontitis (HP:0000704) | 3.63687858 |
| 14 | Recurrent skin infections (HP:0001581) | 3.57661716 |
| 15 | Optic neuritis (HP:0100653) | 3.57006325 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.57006325 |
| 17 | Disinhibition (HP:0000734) | 3.46115051 |
| 18 | Absent frontal sinuses (HP:0002688) | 3.37970184 |
| 19 | Myositis (HP:0100614) | 3.34187306 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.33956140 |
| 21 | Insidious onset (HP:0003587) | 3.25165728 |
| 22 | Termporal pattern (HP:0011008) | 3.25165728 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.23297273 |
| 24 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.23149662 |
| 25 | Flat acetabular roof (HP:0003180) | 3.11753853 |
| 26 | Asymmetry of the thorax (HP:0001555) | 3.08972901 |
| 27 | Obstructive lung disease (HP:0006536) | 3.07195621 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.07195621 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04904343 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.03673587 |
| 31 | Increased IgM level (HP:0003496) | 3.01680811 |
| 32 | Macroorchidism (HP:0000053) | 3.01027781 |
| 33 | Curly hair (HP:0002212) | 3.00197226 |
| 34 | Germ cell neoplasia (HP:0100728) | 2.97573080 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 2.96845505 |
| 36 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.92652957 |
| 37 | Thick nail (HP:0001805) | 2.86872562 |
| 38 | Thyroid carcinoma (HP:0002890) | 2.85917015 |
| 39 | Stomatitis (HP:0010280) | 2.83715948 |
| 40 | Spinal cord lesions (HP:0100561) | 2.82633239 |
| 41 | Syringomyelia (HP:0003396) | 2.82633239 |
| 42 | Hepatoblastoma (HP:0002884) | 2.77702281 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73698412 |
| 44 | Recurrent viral infections (HP:0004429) | 2.71404161 |
| 45 | Vasculitis (HP:0002633) | 2.68997659 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.65254499 |
| 47 | Urinary urgency (HP:0000012) | 2.57724681 |
| 48 | Peritonitis (HP:0002586) | 2.57644660 |
| 49 | Basal ganglia calcification (HP:0002135) | 2.57468652 |
| 50 | Abnormal pancreas size (HP:0012094) | 2.56295749 |
| 51 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.55281090 |
| 52 | Syncope (HP:0001279) | 2.54815937 |
| 53 | Arterial thrombosis (HP:0004420) | 2.50782817 |
| 54 | Spondylolisthesis (HP:0003302) | 2.49391342 |
| 55 | Myocardial infarction (HP:0001658) | 2.49349252 |
| 56 | Dysmetric saccades (HP:0000641) | 2.46670976 |
| 57 | Sudden death (HP:0001699) | 2.46248748 |
| 58 | Tetraparesis (HP:0002273) | 2.45977653 |
| 59 | Thin bony cortex (HP:0002753) | 2.44847589 |
| 60 | Agnosia (HP:0010524) | 2.44006238 |
| 61 | Premature loss of primary teeth (HP:0006323) | 2.42029945 |
| 62 | Glomerulonephritis (HP:0000099) | 2.41453595 |
| 63 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.40306654 |
| 64 | Osteolytic defects of the hand bones (HP:0009699) | 2.38152186 |
| 65 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38152186 |
| 66 | Pheochromocytoma (HP:0002666) | 2.34947790 |
| 67 | Cortical dysplasia (HP:0002539) | 2.34257989 |
| 68 | Neonatal hypoglycemia (HP:0001998) | 2.33191254 |
| 69 | Heterotopia (HP:0002282) | 2.30802514 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.30270225 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.29316767 |
| 72 | Axonal loss (HP:0003447) | 2.29057481 |
| 73 | Ankyloglossia (HP:0010296) | 2.27957615 |
| 74 | Action tremor (HP:0002345) | 2.27690532 |
| 75 | Bundle branch block (HP:0011710) | 2.27597785 |
| 76 | Urticaria (HP:0001025) | 2.25976270 |
| 77 | Pustule (HP:0200039) | 2.25525705 |
| 78 | Hematochezia (HP:0002573) | 2.25383065 |
| 79 | Abnormality of the frontal sinuses (HP:0002687) | 2.22544841 |
| 80 | Inappropriate behavior (HP:0000719) | 2.22483239 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.21508872 |
| 82 | Bone pain (HP:0002653) | 2.21383239 |
| 83 | Absent eyebrow (HP:0002223) | 2.21163358 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19274541 |
| 85 | Mucopolysacchariduria (HP:0008155) | 2.19274541 |
| 86 | Nephritis (HP:0000123) | 2.18593845 |
| 87 | Thoracic kyphosis (HP:0002942) | 2.17662229 |
| 88 | Abnormality of the gastric mucosa (HP:0004295) | 2.16480707 |
| 89 | Abnormality of the prostate (HP:0008775) | 2.16123133 |
| 90 | Hypoplasia of dental enamel (HP:0006297) | 2.15919406 |
| 91 | Osteomyelitis (HP:0002754) | 2.15471847 |
| 92 | Frequent falls (HP:0002359) | 2.14548913 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12969899 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12969899 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12969899 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11381996 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11381996 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11381996 |
| 99 | Abnormality of the pericardium (HP:0001697) | 2.10643314 |
| 100 | Vertebral compression fractures (HP:0002953) | 2.09826344 |
| 101 | Neurofibrillary tangles (HP:0002185) | 2.07301001 |
| 102 | Interstitial pulmonary disease (HP:0006530) | 2.07024382 |
| 103 | Symptomatic seizures (HP:0011145) | 2.06645750 |
| 104 | Acute lymphatic leukemia (HP:0006721) | 2.06540795 |
| 105 | Hyperparathyroidism (HP:0000843) | 2.03607166 |
| 106 | Abnormality of the thoracic spine (HP:0100711) | 2.03304633 |
| 107 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01544195 |
| 108 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01544195 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 2.01080275 |
| 110 | Hydroxyprolinuria (HP:0003080) | 2.01080275 |
| 111 | Joint hemorrhage (HP:0005261) | 2.00549320 |
| 112 | Hypergammaglobulinemia (HP:0010702) | 2.00113758 |
| 113 | Leukocytosis (HP:0001974) | 1.99988932 |
| 114 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.99328863 |
| 115 | Drooling (HP:0002307) | 1.98971724 |
| 116 | Keratoconjunctivitis sicca (HP:0001097) | 1.98432061 |
| 117 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.97043725 |
| 118 | Cellulitis (HP:0100658) | 1.96936511 |
| 119 | Testicular neoplasm (HP:0010788) | 1.96514393 |
| 120 | Hyperventilation (HP:0002883) | 1.96254561 |
| 121 | Ventricular fibrillation (HP:0001663) | 1.95400819 |
| 122 | Abnormality of the nasal septum (HP:0000419) | 1.95152179 |
| 123 | Gingival bleeding (HP:0000225) | 1.95056927 |
| 124 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.94553268 |
| 125 | Hypoglycemic coma (HP:0001325) | 1.93990836 |
| 126 | Relative macrocephaly (HP:0004482) | 1.93264804 |
| 127 | Resting tremor (HP:0002322) | 1.93125232 |
| 128 | Malnutrition (HP:0004395) | 1.91385387 |
| 129 | Cerebral inclusion bodies (HP:0100314) | 1.91056520 |
| 130 | Abnormality of the corticospinal tract (HP:0002492) | 1.87236658 |
| 131 | Cystic hygroma (HP:0000476) | 1.87104604 |
| 132 | Ankle clonus (HP:0011448) | 1.86172016 |
| 133 | Enlarged penis (HP:0000040) | 1.86098510 |
| 134 | Milia (HP:0001056) | 1.85904110 |
| 135 | Pathologic fracture (HP:0002756) | 1.82695015 |
| 136 | Gastrointestinal infarctions (HP:0005244) | 1.82590202 |
| 137 | Excessive salivation (HP:0003781) | 1.81513533 |
| 138 | Recurrent pneumonia (HP:0006532) | 1.81409378 |
| 139 | Apathy (HP:0000741) | 1.79426881 |
| 140 | Cervical subluxation (HP:0003308) | 1.78943448 |
| 141 | Ventricular tachycardia (HP:0004756) | 1.78523376 |
| 142 | Dysdiadochokinesis (HP:0002075) | 1.77783262 |
| 143 | Hemoptysis (HP:0002105) | 1.76857347 |
| 144 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.75887036 |
| 145 | Subaortic stenosis (HP:0001682) | 1.75887036 |
| 146 | Plantar hyperkeratosis (HP:0007556) | 1.75279502 |
| 147 | Keratoconjunctivitis (HP:0001096) | 1.73460647 |
| 148 | Akinesia (HP:0002304) | 1.73216500 |
| 149 | Proximal tubulopathy (HP:0000114) | 1.72851944 |
| 150 | Diminished motivation (HP:0000745) | 1.72482594 |
| 151 | Meningitis (HP:0001287) | 1.71821790 |
| 152 | Abnormal tarsal ossification (HP:0008369) | 1.71372753 |
| 153 | Absent eyelashes (HP:0000561) | 1.71270771 |
| 154 | Depression (HP:0000716) | 1.70646522 |
| 155 | Progressive visual loss (HP:0000529) | 1.69778136 |
| 156 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.69365456 |
| 157 | Eosinophilia (HP:0001880) | 1.69164195 |
| 158 | Joint swelling (HP:0001386) | 1.69070703 |
| 159 | Cubitus valgus (HP:0002967) | 1.68227161 |
| 160 | Epileptiform EEG discharges (HP:0011182) | 1.67726650 |
| 161 | Vertebral arch anomaly (HP:0008438) | 1.67597427 |
| 162 | Abnormal foot bone ossification (HP:0010675) | 1.67370534 |
| 163 | Coarse hair (HP:0002208) | 1.66938824 |
| 164 | Absent speech (HP:0001344) | 1.66787110 |
| 165 | Abdominal distention (HP:0003270) | 1.66538976 |
| 166 | Pili torti (HP:0003777) | 1.65930987 |
| 167 | Febrile seizures (HP:0002373) | 1.65680354 |
| 168 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.65401103 |
| 169 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.65401103 |
| 170 | Exotropia (HP:0000577) | 1.65119732 |
| 171 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.65096794 |
| 172 | Lower limb asymmetry (HP:0100559) | 1.64537298 |
| 173 | EEG with generalized epileptiform discharges (HP:0011198) | 1.64379273 |
| 174 | Visceral angiomatosis (HP:0100761) | 1.64324366 |
| 175 | Porencephaly (HP:0002132) | 1.64241841 |
| 176 | Widely patent fontanelles and sutures (HP:0004492) | 1.63365246 |
| 177 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.63347394 |
| 178 | Lower limb hyperreflexia (HP:0002395) | 1.62252031 |
| 179 | Open mouth (HP:0000194) | 1.62039162 |
| 180 | Hemangiomatosis (HP:0007461) | 1.61393338 |
| 181 | Abnormality of the lumbar spine (HP:0100712) | 1.61015750 |
| 182 | Hyperactive renin-angiotensin system (HP:0000841) | 1.60804237 |
| 183 | Focal seizures (HP:0007359) | 1.60672052 |
| 184 | Leiomyosarcoma (HP:0100243) | 1.60494932 |
| 185 | Sporadic (HP:0003745) | 1.59821398 |
| 186 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.59335219 |
| 187 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.59335219 |
| 188 | Hypsarrhythmia (HP:0002521) | 1.59066449 |
| 189 | Buphthalmos (HP:0000557) | 1.58345348 |
| 190 | Abnormal cortical bone morphology (HP:0003103) | 1.57888819 |
| 191 | Thickened calvaria (HP:0002684) | 1.57119475 |
| 192 | Hypercortisolism (HP:0001578) | 1.55423635 |
| 193 | Neoplasm of the thyroid gland (HP:0100031) | 1.55315459 |
| 194 | Protruding tongue (HP:0010808) | 1.54123254 |
| 195 | Lower limb muscle weakness (HP:0007340) | 1.52380098 |
| 196 | Broad-based gait (HP:0002136) | 1.52248373 |
| 197 | Fat malabsorption (HP:0002630) | 1.51856629 |
| 198 | Overgrowth (HP:0001548) | 1.51731788 |
| 199 | Impaired vibratory sensation (HP:0002495) | 1.51457053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.07366220 |
| 2 | MAP3K14 | 4.53378390 |
| 3 | CASK | 4.44631278 |
| 4 | TYK2 | 2.75024201 |
| 5 | MAP3K13 | 2.72585324 |
| 6 | TBK1 | 2.64466872 |
| 7 | IRAK3 | 2.58089613 |
| 8 | IRAK4 | 2.50612501 |
| 9 | LATS2 | 2.44474824 |
| 10 | BLK | 2.43143049 |
| 11 | JAK1 | 2.26184359 |
| 12 | EEF2K | 2.18648142 |
| 13 | JAK3 | 2.17401334 |
| 14 | IKBKE | 2.17308780 |
| 15 | TAOK3 | 2.02387451 |
| 16 | TRIB3 | 2.02263755 |
| 17 | ICK | 1.99705544 |
| 18 | MST1R | 1.96833136 |
| 19 | SCYL2 | 1.96220089 |
| 20 | IKBKB | 1.87228196 |
| 21 | ERBB3 | 1.76430477 |
| 22 | STK24 | 1.72025382 |
| 23 | PKN2 | 1.70241651 |
| 24 | EPHA4 | 1.70219740 |
| 25 | MAP3K4 | 1.66642921 |
| 26 | MAP3K9 | 1.64080409 |
| 27 | CHUK | 1.63821778 |
| 28 | RIPK1 | 1.57552967 |
| 29 | BMPR2 | 1.56019198 |
| 30 | PBK | 1.55970959 |
| 31 | FRK | 1.52549672 |
| 32 | MAP3K10 | 1.52231192 |
| 33 | CAMK1G | 1.44933150 |
| 34 | PINK1 | 1.43710349 |
| 35 | EPHA2 | 1.39339047 |
| 36 | MAP2K7 | 1.39005311 |
| 37 | STK39 | 1.36577734 |
| 38 | BRD4 | 1.35693592 |
| 39 | RET | 1.33994426 |
| 40 | EIF2AK3 | 1.31736173 |
| 41 | ERN1 | 1.31548188 |
| 42 | SIK3 | 1.29217078 |
| 43 | SGK223 | 1.27764783 |
| 44 | SGK494 | 1.27764783 |
| 45 | FGFR3 | 1.27242209 |
| 46 | MAP3K12 | 1.26798893 |
| 47 | FGFR2 | 1.24757305 |
| 48 | MAP3K6 | 1.24747462 |
| 49 | TXK | 1.23596156 |
| 50 | CSK | 1.21359956 |
| 51 | MAP3K5 | 1.20724491 |
| 52 | NEK9 | 1.17147312 |
| 53 | PIM2 | 1.15706569 |
| 54 | TNIK | 1.14525258 |
| 55 | PRKD3 | 1.13992605 |
| 56 | KIT | 1.10724137 |
| 57 | MAP3K2 | 1.10408802 |
| 58 | KSR2 | 1.09944772 |
| 59 | DAPK2 | 1.09651806 |
| 60 | BMX | 1.08160907 |
| 61 | JAK2 | 1.07269557 |
| 62 | PTK6 | 1.05481837 |
| 63 | EIF2AK2 | 1.04968177 |
| 64 | MAP2K4 | 1.03710238 |
| 65 | MET | 1.03457950 |
| 66 | HCK | 1.03303137 |
| 67 | STK3 | 1.03084215 |
| 68 | MINK1 | 1.00572251 |
| 69 | LATS1 | 0.98792961 |
| 70 | RPS6KA4 | 0.97950829 |
| 71 | KSR1 | 0.95672656 |
| 72 | ACVR1B | 0.95384172 |
| 73 | PLK2 | 0.95314792 |
| 74 | NUAK1 | 0.94361089 |
| 75 | RPS6KB1 | 0.94285618 |
| 76 | NTRK1 | 0.93814147 |
| 77 | YES1 | 0.90140030 |
| 78 | FGR | 0.88847016 |
| 79 | PIK3CA | 0.88191873 |
| 80 | BMPR1B | 0.86622406 |
| 81 | CDK5 | 0.85645318 |
| 82 | SIK1 | 0.85322049 |
| 83 | ABL2 | 0.84471752 |
| 84 | TAOK1 | 0.82250629 |
| 85 | SYK | 0.81818837 |
| 86 | PRKG2 | 0.80775190 |
| 87 | TRPM7 | 0.75636488 |
| 88 | PIM1 | 0.75035247 |
| 89 | RPS6KA2 | 0.74566645 |
| 90 | FER | 0.73420053 |
| 91 | MAP3K1 | 0.73192508 |
| 92 | UHMK1 | 0.72824422 |
| 93 | SIK2 | 0.72802893 |
| 94 | NTRK2 | 0.72720830 |
| 95 | ERBB4 | 0.72640395 |
| 96 | CDK12 | 0.71145500 |
| 97 | NTRK3 | 0.70316236 |
| 98 | MTOR | 0.70005977 |
| 99 | TESK1 | 0.69514308 |
| 100 | SGK3 | 0.69350759 |
| 101 | MAPK10 | 0.69242105 |
| 102 | STK38L | 0.68664402 |
| 103 | EGFR | 0.66281848 |
| 104 | SGK2 | 0.65977380 |
| 105 | WNK1 | 0.65027767 |
| 106 | PRKCD | 0.64799597 |
| 107 | EPHB2 | 0.64461993 |
| 108 | FGFR4 | 0.64309579 |
| 109 | CSNK1E | 0.63286587 |
| 110 | MARK3 | 0.61547007 |
| 111 | MARK1 | 0.59097402 |
| 112 | CSNK1G2 | 0.58741978 |
| 113 | SGK1 | 0.57619457 |
| 114 | LYN | 0.57562338 |
| 115 | AKT3 | 0.57213615 |
| 116 | CAMKK1 | 0.57187914 |
| 117 | CSNK1A1L | 0.56727433 |
| 118 | ABL1 | 0.56468899 |
| 119 | PNCK | 0.55565707 |
| 120 | FES | 0.54459521 |
| 121 | MATK | 0.54185979 |
| 122 | MOS | 0.53112738 |
| 123 | MKNK2 | 0.53015676 |
| 124 | LCK | 0.51718972 |
| 125 | CDK3 | 0.50768540 |
| 126 | TTN | 0.50680411 |
| 127 | HIPK2 | 0.50585752 |
| 128 | STK11 | 0.50287606 |
| 129 | ARAF | 0.48876696 |
| 130 | ZAP70 | 0.48486232 |
| 131 | DAPK1 | 0.47512212 |
| 132 | ERBB2 | 0.46909248 |
| 133 | PDPK1 | 0.46835860 |
| 134 | PRKCE | 0.46492488 |
| 135 | MST4 | 0.46470822 |
| 136 | PASK | 0.46259083 |
| 137 | RPS6KB2 | 0.46094049 |
| 138 | ALK | 0.45112995 |
| 139 | CDK6 | 0.44899654 |
| 140 | PDGFRA | 0.44688805 |
| 141 | PRKCH | 0.44600224 |
| 142 | PIK3CG | 0.44590076 |
| 143 | LMTK2 | 0.44096652 |
| 144 | PDGFRB | 0.43669135 |
| 145 | BCR | 0.43174741 |
| 146 | FYN | 0.42567233 |
| 147 | EPHA3 | 0.42501810 |
| 148 | CSF1R | 0.42455422 |
| 149 | CAMK1D | 0.41552403 |
| 150 | DDR2 | 0.39775111 |
| 151 | TAF1 | 0.39745229 |
| 152 | DMPK | 0.39694220 |
| 153 | PDK1 | 0.37460903 |
| 154 | NEK6 | 0.36594369 |
| 155 | STK4 | 0.36359250 |
| 156 | RPS6KA3 | 0.36112847 |
| 157 | PRKCZ | 0.36023864 |
| 158 | RAF1 | 0.35727751 |
| 159 | PRKAA1 | 0.35607468 |
| 160 | PRKAA2 | 0.35050644 |
| 161 | TYRO3 | 0.34997382 |
| 162 | CDK14 | 0.34508313 |
| 163 | PRPF4B | 0.33962419 |
| 164 | EPHB1 | 0.33752472 |
| 165 | STK10 | 0.32934934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.09475274 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.82999487 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.56089069 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50356540 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.21520512 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.14532900 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.06695522 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.06587208 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02688832 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00909139 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.00488582 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.90132053 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.87141658 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.87053262 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 1.83904827 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82929487 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.79969554 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78511477 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.77516060 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75381529 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72319403 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.69245856 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.68273781 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.65729144 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.59248415 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57444727 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52314974 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50965050 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48575395 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.47976850 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46974193 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46838939 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.42849663 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.42409423 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41825645 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41725467 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.39066534 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.37396263 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35397470 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.32670836 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31682056 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29614078 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.26968022 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.24938140 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.23110182 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.21988585 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.18943208 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18804381 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18295516 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18008690 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17409868 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.15948291 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14385066 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.14174260 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13526588 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.13388826 |
| 57 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13124770 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13063086 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12013400 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11628394 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10272150 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 1.09569219 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07631251 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 1.07477429 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.07100777 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06401741 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04643973 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03923559 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.03831449 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02137826 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01050862 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00317750 |
| 73 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.98733833 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98058467 |
| 75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97095579 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96839048 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96313844 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.96260588 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95856149 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95091171 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93891062 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92675943 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92337211 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91950424 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91652609 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91164114 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90891620 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.90092156 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89570357 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.88602191 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88408046 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.88272690 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87496788 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87307030 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86564815 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85965003 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85488994 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83885002 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83399058 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83377700 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81900169 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81320955 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81246388 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80517972 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78827338 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78137484 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77065412 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76590582 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.75988971 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75830027 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75521296 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74521289 |
| 113 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74087703 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.73373051 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70649425 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70368430 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68664037 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68007438 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67576388 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67005493 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66308027 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.65587651 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64818646 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64252177 |
| 125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63898629 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63532766 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63266553 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61651188 |
| 129 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61313439 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.59997109 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59504625 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57396415 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57377066 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.57008825 |
| 135 | Lysine degradation_Homo sapiens_hsa00310 | 0.56665814 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.56548584 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56484676 |
| 138 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56477121 |
| 139 | Adherens junction_Homo sapiens_hsa04520 | 0.56262335 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55942692 |
| 141 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55243753 |
| 142 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55218878 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52105513 |
| 144 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51698776 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50769553 |
| 146 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50018774 |
| 147 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49636145 |
| 148 | Alcoholism_Homo sapiens_hsa05034 | 0.49432121 |
| 149 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48888564 |
| 150 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48001126 |
| 151 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47478994 |
| 152 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47312575 |
| 153 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46998707 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.45784441 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44802718 |
| 156 | Focal adhesion_Homo sapiens_hsa04510 | 0.42167604 |
| 157 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42167239 |
| 158 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42125722 |
| 159 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40679497 |
| 160 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38771472 |
| 161 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38016702 |
| 162 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37053855 |
| 163 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36912690 |
| 164 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35977579 |
| 165 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35390845 |
| 166 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34800304 |
| 167 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33376488 |
| 168 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32781351 |
| 169 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31568230 |
| 170 | Prostate cancer_Homo sapiens_hsa05215 | 0.30627478 |

